Arcus Biosciences, Inc. (RCUS:NYSE) soared at $15.74, representing a gain of 26.6%. On Tue 18 Feb 20, RCUS:NYSE touched a New 2-Week High of $12.43. The stock appeared on our News Catalysts scanner on Wed 12 Feb 20 at 05:05 PM in the 'MISCELLANEOUS' category. From Tue 28 Jan 20, the stock recorded 42.86% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arcus Biosciences, Inc. (RCUS:NYSE)
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 79.64%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 44.55%
- Myomo, Inc. (MYO:NYSEMKT), 43.41%
- Enphase Energy, Inc. (ENPH:NASDAQ), 42.44%
- ShotSpotter, Inc. (SSTI:NASDAQ), 32.56%
- Viveve Medical, Inc. (VIVE:NASDAQ), 32.35%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 30.43%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 30.4%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 28.41%
- Arcus Biosciences, Inc. (RCUS:NYSE), 26.63%